MemNovo: Look Back at the Spectrum for Balanced De Novo Peptide Sequencing from Mass Spectrometry

• URL: http://arxiv.org/abs/2606.11868v1
• Date: Wed, 10 Jun 2026 09:43:30 GMT
• Title: MemNovo: Look Back at the Spectrum for Balanced De Novo Peptide Sequencing from Mass Spectrometry
• Abstract summary: We propose MemNovo, a training-free and plug-and-play mechanism that re-balances peptide and spectral contributions at inference time.<n>MemNovo consistently improves both amino acid precision and peptide precision, achieving up to 39.1% relative improvement in peptide precision for Casanovo and up to 3.9% for InstaNovo.
• Score: 21.22527431134635
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: De novo peptide sequencing from tandem mass spectrometry is pivotal in proteomics, enabling identification of novel peptides without reference databases. While recent Transformer-based encoder-decoder models have achieved remarkable performance, we uncover a critical pathology in their inference dynamics. Through comprehensive feature scaling experiments, we demonstrate that existing auto-regressive peptide decoders tend to over-rely on generated-sequence priors while progressively under-utilizing fine-grained physical evidence from the input mass spectrum. This phenomenon leads to suboptimal results, where generated peptide sequences are biologically plausible yet not faithful to the input spectrum. To rectify this, we propose MemNovo, a training-free and plug-and-play mechanism that re-balances peptide and spectral contributions at inference time. MemNovo alleviates the information bottleneck by establishing a persistent spectral memory bank and injecting retrieved features directly into the final decoding stage via an ultra-conservative residual connection. Theoretical analysis confirms that this mechanism restores the mutual information between the decoder state and the raw spectrum. Extensive experiments on the Nine Species benchmark with two representative baselines, Casanovo and InstaNovo, demonstrate that MemNovo consistently improves both amino acid precision and peptide precision, achieving up to 39.1% relative improvement in peptide precision for Casanovo and up to 3.9% for InstaNovo, with negligible computational overhead.

Related papers

• Regressor-guided Diffusion Model for De Novo Peptide Sequencing with Explicit Mass Control [21.55210993203977]
  We introduce DiffuNovo, a regressor-guided diffusion model for de novo peptide sequencing that provides explicit peptide-level mass control.<n>Our approach integrates the mass constraint at two critical stages: during training, a novel peptide-level mass loss guides model optimization, while at inference, regressor-based guidance from gradient-based updates in the latent space steers the generation to compel the predicted peptide adheres to the mass constraint.
  arXiv  Detail & Related papers  (2026-02-23T03:26:25Z)
• Diffusion Decoding for Peptide De Novo Sequencing [71.91773485443125]
  This paper investigates using diffusion decoders adapted for the discrete data domain.<n>These decoders provide a different approach, allowing sequence generation to start from any peptide segment.<n>Although peptide precision and recall were still 0, the best diffusion decoder design with the DINOISER loss function obtained a statistically significant improvement in amino acid recall by 0.373.
  arXiv  Detail & Related papers  (2025-07-15T03:38:01Z)
• Universal Biological Sequence Reranking for Improved De Novo Peptide Sequencing [32.29218860420551]
  RankNovo is the first deep reranking framework that enhances de novo peptide sequencing.<n>Our work presents a novel reranking strategy that challenges existing single-model paradigms and advances the frontier of accurate de novo sequencing.
  arXiv  Detail & Related papers  (2025-05-23T06:56:55Z)
• NovoBench: Benchmarking Deep Learning-based De Novo Peptide Sequencing Methods in Proteomics [58.03989832372747]
  We present the first unified benchmark NovoBench for emphde novo peptide sequencing. It comprises diverse mass spectrum data, integrated models, and comprehensive evaluation metrics. Recent methods, including DeepNovo, PointNovo, Casanovo, InstaNovo, AdaNovo and $pi$-HelixNovo are integrated into our framework.
  arXiv  Detail & Related papers  (2024-06-16T08:23:21Z)
• AdaNovo: Adaptive \emph{De Novo} Peptide Sequencing with Conditional Mutual Information [46.23980841020632]
  We propose AdaNovo, a novel framework that calculates conditional mutual information (CMI) between the spectrum and each amino acid/peptide. AdaNovo excels in identifying amino acids with post-translational modifications (PTMs) and exhibits robustness against data noise.
  arXiv  Detail & Related papers  (2024-03-09T11:54:58Z)
• ContraNovo: A Contrastive Learning Approach to Enhance De Novo Peptide Sequencing [70.12220342151113]
  ContraNovo is a pioneering algorithm that leverages contrastive learning to extract the relationship between spectra and peptides. ContraNovo consistently outshines contemporary state-of-the-art solutions.
  arXiv  Detail & Related papers  (2023-12-18T12:49:46Z)
• Efficient Prediction of Peptide Self-assembly through Sequential and Graphical Encoding [57.89530563948755]
  This work provides a benchmark analysis of peptide encoding with advanced deep learning models. It serves as a guide for a wide range of peptide-related predictions such as isoelectric points, hydration free energy, etc.
  arXiv  Detail & Related papers  (2023-07-17T00:43:33Z)
• EBM-Fold: Fully-Differentiable Protein Folding Powered by Energy-based Models [53.17320541056843]
  We propose a fully-differentiable approach for protein structure optimization, guided by a data-driven generative network. Our EBM-Fold approach can efficiently produce high-quality decoys, compared against traditional Rosetta-based structure optimization routines.
  arXiv  Detail & Related papers  (2021-05-11T03:40:29Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.